Riesgo de enfermedad tromboembólica venosa en pacientes hospitalizados no quirúrgicos. Grado de acuerdo entre la guía PRETEMED y las recomendaciones de la viii conferencia del American College of Chest Physicians
Tài liệu tham khảo
Alikhan, 2004, Fatal pulmonary embolism in hospitalised patients: a necropsy review, J Clin Pathol, 57, 1254, 10.1136/jcp.2003.013581
Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 381, 10.1378/chest.08-0656
Alikhan, 2008, Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease, Am J Med, 121, 935, 10.1016/j.amjmed.2008.05.045
Guijarro Merino, 2008, Epidemiología hospitalaria de la enfermedad tromboembólica venosa en España, Med Clin (Barc), 131, 2, 10.1016/S0025-7753(08)76442-X
Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0
Bergmann, 2010, Venous tromboembolism risk and prophylaxis in hospitalised medically ill patients, Thromb Haemost, 103, 736, 10.1160/TH09-09-0667
Nieto Rodríguez, 2009, Riesgo de enfermedad tromboembólica venosa y profilaxis antitrombótica en los pacientes ingresados en hospitales españoles (estudio ENDORSE), Med Clin (Barc), 133, 1, 10.1016/j.medcli.2009.01.040
Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103
Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24
Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C
Dentali, 2007, Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients, Ann Intern Med, 146, 278, 10.7326/0003-4819-146-4-200702200-00007
Monreal, 2004, The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry, J Thromb Haemost, 2, 1892, 10.1111/j.1538-7836.2004.01012.x
Hull, 2010, Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial, Ann Intern Med, 153, 8, 10.7326/0003-4819-153-1-201007060-00004
Medrano Ortega FJ, Navarro Puerto A, Vidal Serrano S, Alonso Ortiz del Río C, Gutierrez Tous R, Martín León I, et al. Guía PRETEMED 2007 sobre prevención de enfermedad tromboembólica venosa en patología médica. Córdoba: SADEMI; 2007. Disponible en: http://www.sademi.com/actividades/publicaciones/guia_medica_pretemed_2007.pdf
Navarro Puerto, 2010, Guías clínicas para la prevención de la enfermedad tromboembólica venosa en ancianos, Med Clin (Barc), 135, 237, 10.1016/j.medcli.2009.05.035
Tapson, 2007, Venous thromboembolism prophylaxis in acutely ill hospitalised medical patients: findings from the international medical prevention registry on venous thromboembolism (IMPROVE), Chest, 132, 936, 10.1378/chest.06-2993
Amin, 2007, Thromboprophylaxis rates in US medical centers: success or failure?, J Thromb Haemost, 5, 1610, 10.1111/j.1538-7836.2007.02650.x
Borobia, 2009, Riesgo de enfermedad tromboembólica y estudio de utilización de tromboprofilaxis en pacientes médicos hospitalizados y al alta hospitalaria, Rev Clin Esp, 209, 15, 10.1016/S0014-2565(09)70353-4
Kahn, 2007, Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada, Thromb Res, 119, 145, 10.1016/j.thromres.2006.01.011
Amin, 2010, Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start), J Thromb Thrombolysis, 29, 326, 10.1007/s11239-009-0361-z
Villar Fernández, 2004, Evaluación de la utilización de heparinas de bajo peso molecular como profilaxis de tromboembolismo venoso en pacientes de medicina interna, Farm Hosp, 28, 402
Roderick, 2005, Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis, Health Technol Assess, 9, 1, 10.3310/hta9490
Dennis, 2009, Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial, Lancet, 373, 1958, 10.1016/S0140-6736(09)60941-7
Decousus, 2011, Factors at admission associated with bleeding risk in medical patients. Findings from the IMPROVE investigators, Chest, 139, 69, 10.1378/chest.09-3081
Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for venous thromboembolism, Chest, 140, 706, 10.1378/chest.10-1944
Kucher, 2005, Electronic alerts to prevent venous thromboembolism among hospitalized patients, N Engl J Med, 352, 969, 10.1056/NEJMoa041533
Páramo, 2009, Enfermedad tromboembólica venosa: una llamada urgente a la acción, Med Clin (Barc), 133, 547, 10.1016/j.medcli.2009.02.049
